Nov. 30 COVID-19 Update: 90 Active Cases, 25 in COVID Unit at CMFH-SS
Hopkins County/Sulphur Springs Emergency Management officials in the Nov. 30 COVID-19 update reported 90 active COVID-19 cases in Hopkins County and 25 patients in the COVID Unit at CHRISTUS Mother Frances Hospital-Sulphur Springs. Texas Department of State Health Services also on Monday, Nov. 30 reported the COVID-19 percentage of hospital patients in Trauma Service Area F remained above 15 percent for the third consecutive day in a...
Nov. 24 COVID-19 Update: 24 In COVID Unit, 58 Active Cases
Hopkins County/Sulphur Springs Emergency Management officials’ Nov. 24 COVID-19 update showed cumulative totals with 11 additional positive COVID-19 cases and 69 additional recoveries over their last report on Nov. 20. HC/SSEM also provided some additional demographic details for recent COVID-19 cases provided by DSHS. Changes in State Reporting The HC/SSEM officials in a Zoom press conference Tuesday afternoon noted that county...
Nov. 23 COVID-19 Update: 22 In Hospital COVID Unit, Changes In Case Reporting
Hopkins County/Sulphur Springs Emergency Management officials in the Nov. 23 COVID-19 update reported a whopping 22 patients in the COVID unit at the hospital and a change in state COVID-19 case reporting. Texas Department of State Health Services, as of Sunday, Nov. 22, will no long be providing daily updates to county officials, HC/SSEM reported in the Nov. 23 COVID-19 update. No new positive cases nor new recoveries were noted by...
FDA Approves First Oral Treatment For COVID-19 In Adults
May 26, 2023 – Today, the U.S. Food and Drug Administration approved the oral antiviral Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including hospitalization or death. Paxlovid is the fourth drug—and first oral antiviral pill—approved by the FDA to treat COVID-19 in adults....
CHRISTUS Mother Frances Hospital News Release 4/4/2023
Sulphur Springs, Texas, April 3, 2023 – CHRISTUS Mother Frances Hospital – Sulphur Springs has ONE mission: To Extend the Healing Ministry of Jesus Christ. Inpatient Rehabilitation If you have a loved one that has recently suffered a stroke, had a major fall and required hospitalization, or even has a planned joint replacement: inpatient rehabilitation might be an option. CHRISTUS Mother Frances Hospital-Sulphur Springs provides...
Lights of Life Gala Sponsorship Opportunities
Business News — January 16, 2023: CHRISTUS Mother Frances Hospital -Sulphur Springs has ONE mission: To Extend the Healing Ministry of Jesus Christ. Hopkins County Health Care Foundation By Jennifer Heitman, Senior Market Development, CHRISTUS Mother Frances Hospital – Sulphur Springs, [email protected] The 2023 Lights of Life Gala Sponsorships are now available. The sponsorship levels are priced the same as last...
USFDA Authorizes Bivalent COVID-19 Vaccines For Children Down To 6 Months of Age
FDA NEWS RELEASE — December 8, 2022 Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the updated (bivalent) Moderna and Pfizer-BioNTech COVID-19 vaccines to include use in children down to 6 months of age. “More children now have the opportunity to update their protection against COVID-19 with a bivalent COVID-19 vaccine, and we encourage parents and caregivers of those eligible to...
Sulphur Springs City Manager’s Report — July 5, 2022
Sulphur Springs City Manager Marc Maxwell presented the following report to the City Council during the regular monthly council meeting on Tuesday, July 5, 2022. Claims We had four workers compensation claims in June. Two were serious enough to result in lost time. One resulted in hospitalization. Both of the more serious injuries were in the Capital Construction Division. (The more serious injury a worker fell off the back of the...
Coronavirus (COVID-19) Update: FDA Approves First COVID-19 Treatment For Young Children
Today, the U.S. Food and Drug Administration expanded the approval to Gilead Sciences Inc. of the COVID-19 treatment Veklury (remdesivir) to include pediatric patients 28 days of age and older weighing at least 3 kilograms (about 7 pounds) with positive results of direct SARS-CoV-2 viral testing, who are: Hospitalized, orNot hospitalized and have mild-to-moderate COVID-19 and are at high risk for progression to severe COVID-19,...
USFDA Authorizes Second Booster Dose Of Pfizer, Moderna COVID-19 Vaccines For Ages 50 And Up And Immunocompromised Individuals
Today (March 28, 2022), the U.S. Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals. The FDA previously authorized a single booster dose for certain immunocompromised individuals following completion of a three-dose primary vaccination series. This makes a second booster dose of both vaccines available...
